(Q30310414)

English

Development status of miltefosine as first oral drug in visceral and cutaneous leishmaniasis

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2017

Development status of miltefosine as first oral drug in visceral and cutaneous leishmaniasis (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2017

cutaneous leishmaniasis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Richard D. Pearson

1

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2017

publication date

1 February 2003

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2017

Current infectious disease reports

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2017

41-42

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2017

Short-course of oral miltefosine for treatment of visceral leishmaniasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/12525289

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/12525289

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Trial of oral miltefosine for visceral leishmaniasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/12525289

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral treatment of visceral leishmaniasis with miltefosine

1 reference

https://pubmed.ncbi.nlm.nih.gov/12525289

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of American cutaneous leishmaniasis with miltefosine, an oral agent

1 reference

https://pubmed.ncbi.nlm.nih.gov/12525289

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral miltefosine for Indian visceral leishmaniasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/12525289

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The activity of alkyl phosphorylcholines and related derivatives against Leishmania donovani

1 reference

https://pubmed.ncbi.nlm.nih.gov/12525289

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11908-003-0063-1

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30310414&oldid=1584436729"